FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017540562> ?p ?o ?g. }

• W2017540562 abstract "The measurement of serum human epidermal growth factor receptor 2 (HER2) extracellular domain levels is a well-established method for evaluating whether a metastatic HER2-positive breast cancer patient will respond to HER2-targeted treatment. However, little is known about the value of serum HER2 for detecting disease relapse following curative surgical treatment in breast cancer patients. The purpose of this study was to evaluate the sensitivity of serum HER2, carcinoembryonic antigen (CEA), and carcinoma antigen 15-3 (CA 15-3) for the detection of disease recurrence in postoperative breast cancer patients with a primary HER2-positive tumor.Serial measurements were taken of serum HER2, CEA, and CA 15-3 levels in patients with primary invasive HER2-positive breast cancer who underwent curative surgical treatment between January 2008 and December 2010. Following treatment, serum HER2 levels were monitored every 6 months using a chemiluminescence immunoassay.Overall, 264 patients were analyzed in this retrospective study. The median follow-up period was 27.7 months, and 24 patients relapsed during follow-up. The sensitivity of serum HER2, CEA, and CA 15-3 for the detection of disease recurrence was 37.5%, 25.1%, and 12.5%, respectively. Sensitivity increased to 45.8% when all three tumor markers were combined in the analysis. In a subgroup of patients without liver disease, the sensitivity of serum HER2, CEA, and CA 15-3 was 57.1%, 21.4%, and 14.3%, respectively. Of the 264 patients in this study, 80 patients had chronic hepatitis, liver cirrhosis, or abnormal aspartate aminotransferase or alanine aminotransferase levels during the follow-up period. Following the exclusion of these patients, the sensitivity of serum HER2 for the detection of disease recurrence increased to 57.1%.Serial serum HER2 measurement may be useful for the detection of disease relapse in patients with HER2-positive breast cancer. Abnormal liver function can result in elevated serum HER2 in the absence of disease recurrence." @default.
• W2017540562 created "2016-06-24" @default.
• W2017540562 creator A5006019721 @default.
• W2017540562 creator A5013334833 @default.
• W2017540562 creator A5013544822 @default.
• W2017540562 creator A5024505376 @default.
• W2017540562 creator A5037531553 @default.
• W2017540562 creator A5038146166 @default.
• W2017540562 creator A5040571052 @default.
• W2017540562 creator A5051411880 @default.
• W2017540562 creator A5059483605 @default.
• W2017540562 creator A5059686120 @default.
• W2017540562 creator A5067962215 @default.
• W2017540562 creator A5079799497 @default.
• W2017540562 date "2014-01-01" @default.
• W2017540562 modified "2023-09-24" @default.
• W2017540562 title "Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients" @default.
• W2017540562 cites W176192392 @default.
• W2017540562 cites W1975936012 @default.
• W2017540562 cites W1993871753 @default.
• W2017540562 cites W2002777645 @default.
• W2017540562 cites W2009218955 @default.
• W2017540562 cites W2031257280 @default.
• W2017540562 cites W2050068687 @default.
• W2017540562 cites W2079161585 @default.
• W2017540562 cites W2110442763 @default.
• W2017540562 cites W2117305280 @default.
• W2017540562 cites W2141393790 @default.
• W2017540562 cites W2143362749 @default.
• W2017540562 cites W2150662879 @default.
• W2017540562 cites W2165713146 @default.
• W2017540562 cites W2170481258 @default.
• W2017540562 cites W2340898473 @default.
• W2017540562 cites W2397597031 @default.
• W2017540562 cites W63132446 @default.
• W2017540562 doi "https://doi.org/10.4048/jbc.2014.17.1.33" @default.
• W2017540562 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3988340" @default.
• W2017540562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24744795" @default.
• W2017540562 hasPublicationYear "2014" @default.
• W2017540562 type Work @default.
• W2017540562 sameAs 2017540562 @default.
• W2017540562 citedByCount "11" @default.
• W2017540562 countsByYear W20175405622015 @default.
• W2017540562 countsByYear W20175405622016 @default.
• W2017540562 countsByYear W20175405622017 @default.
• W2017540562 countsByYear W20175405622018 @default.
• W2017540562 countsByYear W20175405622019 @default.
• W2017540562 countsByYear W20175405622021 @default.
• W2017540562 crossrefType "journal-article" @default.
• W2017540562 hasAuthorship W2017540562A5006019721 @default.
• W2017540562 hasAuthorship W2017540562A5013334833 @default.
• W2017540562 hasAuthorship W2017540562A5013544822 @default.
• W2017540562 hasAuthorship W2017540562A5024505376 @default.
• W2017540562 hasAuthorship W2017540562A5037531553 @default.
• W2017540562 hasAuthorship W2017540562A5038146166 @default.
• W2017540562 hasAuthorship W2017540562A5040571052 @default.
• W2017540562 hasAuthorship W2017540562A5051411880 @default.
• W2017540562 hasAuthorship W2017540562A5059483605 @default.
• W2017540562 hasAuthorship W2017540562A5059686120 @default.
• W2017540562 hasAuthorship W2017540562A5067962215 @default.
• W2017540562 hasAuthorship W2017540562A5079799497 @default.
• W2017540562 hasBestOaLocation W20175405621 @default.
• W2017540562 hasConcept C121608353 @default.
• W2017540562 hasConcept C126322002 @default.
• W2017540562 hasConcept C143998085 @default.
• W2017540562 hasConcept C2777214474 @default.
• W2017540562 hasConcept C2777387746 @default.
• W2017540562 hasConcept C530470458 @default.
• W2017540562 hasConcept C71924100 @default.
• W2017540562 hasConcept C90924648 @default.
• W2017540562 hasConceptScore W2017540562C121608353 @default.
• W2017540562 hasConceptScore W2017540562C126322002 @default.
• W2017540562 hasConceptScore W2017540562C143998085 @default.
• W2017540562 hasConceptScore W2017540562C2777214474 @default.
• W2017540562 hasConceptScore W2017540562C2777387746 @default.
• W2017540562 hasConceptScore W2017540562C530470458 @default.
• W2017540562 hasConceptScore W2017540562C71924100 @default.
• W2017540562 hasConceptScore W2017540562C90924648 @default.
• W2017540562 hasLocation W20175405621 @default.
• W2017540562 hasLocation W20175405622 @default.
• W2017540562 hasLocation W20175405623 @default.
• W2017540562 hasLocation W20175405624 @default.
• W2017540562 hasOpenAccess W2017540562 @default.
• W2017540562 hasPrimaryLocation W20175405621 @default.
• W2017540562 hasRelatedWork W1483287748 @default.
• W2017540562 hasRelatedWork W1761069005 @default.
• W2017540562 hasRelatedWork W1989227752 @default.
• W2017540562 hasRelatedWork W2028493119 @default.
• W2017540562 hasRelatedWork W2033201741 @default.
• W2017540562 hasRelatedWork W2040350050 @default.
• W2017540562 hasRelatedWork W2045276213 @default.
• W2017540562 hasRelatedWork W2052129612 @default.
• W2017540562 hasRelatedWork W2176146391 @default.
• W2017540562 hasRelatedWork W2362839025 @default.
• W2017540562 hasRelatedWork W2365516749 @default.
• W2017540562 hasRelatedWork W2371019053 @default.
• W2017540562 hasRelatedWork W2375981839 @default.
• W2017540562 hasRelatedWork W2378276305 @default.
• W2017540562 hasRelatedWork W2411238598 @default.
• W2017540562 hasRelatedWork W2909703705 @default.

• next